Discontinued — last reported Q3 '23
IQVIA Equity Method Investments increased by 10.2% to $357.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 41.1%, from $253.00M to $357.00M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 31.0% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.00M | $84.00M | $88.00M | $90.00M | $92.00M | $87.00M | $94.00M | $99.00M | $107.00M | $115.00M | $134.00M | $154.00M | $181.00M | $203.00M | $266.00M | $253.00M | $272.00M | $275.00M | $324.00M | $357.00M |
| QoQ Change | — | +0.0% | +4.8% | +2.3% | +2.2% | -5.4% | +8.0% | +5.3% | +8.1% | +7.5% | +16.5% | +14.9% | +17.5% | +12.2% | +31.0% | -4.9% | +7.5% | +1.1% | +17.8% | +10.2% |
| YoY Change | — | — | — | — | +9.5% | +3.6% | +6.8% | +10.0% | +16.3% | +32.2% | +42.6% | +55.6% | +69.2% | +76.5% | +98.5% | +64.3% | +50.3% | +35.5% | +21.8% | +41.1% |